Skip to main content
. 2020 Dec 3;60(5):2663–2667. doi: 10.1002/anie.202012956

Figure 3.

Figure 3

In vivo fluorescence imaging of HepG‐2 tumor (left upper chest) and liver site (upper abdomen) after intravenous injection of NIR797‐doped dt‐MIP, SA‐MIP, DFCR‐MIP, NIP and PBS for different times.